We previously established that PTPN13 mRNA expression level is an independent prognostic indicator of favorable outcome for patients with breast cancer 23, and that PTPN13 protein levels are decreased in primary and metastatic breast cancer compared with normal breast tissue 13. The gene discussed is PTPN13; the disease is breast carcinoma.